| | Unfavourable () | Favourable () | Odds ratio (95% CI)* |
| Age (yr)āmean Ā± SD | 21 Ā± 30 | 20 Ā± 32 | ā | Malesā% | 65 | 51 | ā | Duration symptoms before admission (hr)āmean Ā± SD | 45 Ā± 45 | 34 Ā± 41 | ā | Duration symptoms before admission <24āhrsāno./tot. no. (%) | 10/17 (59) | 36/48 | 0.48 (0.15ā1.53) | Received dexamethasoneāno./tot. no. (%) | 11/17 (65) | 33/49 (67) | 0.89 (0.18ā2.84) | Received AB in last 48āhrāno./tot. no. (%) | 4/17 (24) | 9/48 (19) | 1.33 (0.35ā5.06) | Coexisting conditionsāno./tot. no. (%) | | | | āOtitis/sinusitis | 2/17 (12) | 15/49 (31) | 0.30 (0.061ā1.49) | āPneumoniae | 3/17 (18) | 4/49 (8) | 2.41 (0.48ā12.09) | āImmunocompromise | 4/17 (24) | 3/49 (6) | 4,72 (0,96ā23,8) | Convulsions on admissionāno./tot. no. (%) | 7/17 (41) | 6/49 (12) | 5,0 (1,4ā18,2) | Findings on admissionāno./tot. no. (%) | | | | āNormal consciousness | 2/17 (12) | 31/49 (63) | 0,07 (0,02ā0,38) | āGCS score < 8 | 4/10 (40) | 2/40 (5) | 12.67 (1.89ā84.97) | āFocal neurological signs | 5/17 (29) | 2/49 (4) | 9,8 (1,69ā56,8) | āTemperature > 38Ā°C | 13/17 (76) | 34/48 (71) | 1.34 (0.37ā44.82) | āTriad (neck stiffness, fever, and altered mental status) | 4/11 (36) | 10/35 (28) | 1.43 (0.34ā5.97) | āPetechiae | 1/17 (6) | 21/49 (43) | 0,08 (0,01ā0,68) | CSF cultureāno./tot. no. (%) | | | | āS. pneumonia | 12/17 (70) | 15/49 (31) | 5,44 (1,62ā18,2) | āN. meningitidis | 3/17 (18) | 17/49 (35) | 0,4 (0,102ā1,60) | āOther bacteria | 1/17 (6) | 8/49 (16) | 0.32 (0.037ā2.77) | āNegative culture | 1/17 (6) | 9/49 (18) | 0.28 (0.032ā2.37) | CSF parameters | | | | āPositive bacterial cultureāno./tot. no. (%) | 16/16 (100) | 38/49 (78) | ā | āWBC (/mm3)āmean Ā± SD | 3401 Ā± 7211 | 6057 Ā± 8156 | ā | āWBC < 1000/mm3āno./tot. no. (%) | 10/13 (77) | 15/49 (31) | 7,6 (1,82ā31,4) | āProteins (mg/dL)āmean Ā± SD | 558 Ā± 557 | 305 Ā± 263 | ā | āProteins > 500āmg/dLāno/tot no (%) | 6/13 (46) | 12/49 (24) | 2,64 (0,74ā9,39) | āGlucose (mg/dL)āmean Ā± SD | 18,5 Ā± 21,8 | 35,6 Ā± 25,1 | ā | āGlucose < 20āmg/dLāno/tot no (%) | 11/13 (85) | 20/49 (41) | 7,98 (1,59ā39,9) | āGlucose CSF/serum ratio (%)āmean Ā± SD | 16 Ā± 14 | 28 Ā± 20 | ā | āLactate (mmol/L)āmean Ā± SD | 12,3 Ā± 4,9 | 8,0 Ā± 5,0 | ā | āLactate > 10āmmol/Lāno./tot. no. (%) | 7/9 (78) | 15/44 (34) | 6,77 (1,25ā36,7) | Positive blood culture, no./tot. no. (%) | 9/16 (56) | 22/48 (56) | 1.52 (0.49ā4.75) | Blood parameters | | | | āHb** (g/dL)āmean Ā± SD | 10,8 Ā± 2,4 | 12,0 Ā± 1,9 | ā | āPlatelets (Ć103/mm3)āmean Ā± SD | 269 Ā± 143 | 280 Ā± 148 | ā | āCRP*** (mg/L)āmean Ā± SD | 258 Ā± 119 | 176 Ā± 128 | ā | āCRP > 200āmg/Lāno./tot. no. (%) | 12/17 (70) | 19/49 (39) | 3,78 (1,15ā12,5) | āHyponatremia** in first 72uāno./tot. no. (%) | 4/17 (24) | 2/49 (4) | 7,23 (1,19ā43,9) | Referred from an other hospitalāno./tot. no. (%) | 10/17 (59) | 9/49 (18) | 6,35 (1,9ā21,2) |
|
|